Benzinga | May 19, 2021 05:46PM EDT

Taro Pharmaceutical Indus Q4 EPS $(0.78) Down From $1.42 YoY, Sales $148.30M Beat $147.33 Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly losses of $0.81 per share. The company reported quarterly tarot Pharmaceutical Indus (NYSE:TARO) reported quarterly losses of $0.81 per share. The company reported quarterly sales of $148.30 million which beat the analyst consensus estimate of $147.33 by 100.66M percent. This is a 15.23 percent decrease over sales of $174.94 million the same period last year.